Skip to main content

Clinical Significance of β2 Glycoprotein I Dependent Anticardiolipin Antibody, Lupus Anticoagulant and Antinuclear Antibodies in Patients with Recurrent Miscarriages

  • Chapter
Reproductive Immunology

Abstract

Antiphospholipid antibodies (aPL) are common as a predictive variable for autoimmunity related miscarriages. However, it is controversial whether antinuclear antibody (ANA)-positive patients should be treated with any medication, because it is unclear whether ANAs are in fact pathogenic. The present study focuses on the possible association betweenβ2 glycoprotein IQ32GPI) dependent anticardiolipin antibody (aCL), lupus anticoagulant (LA) and ANA and the clinical significance of ANA in patients with recurrent miscarriages. We have studied 301 patients with a history of two or more miscarriages. β2GPI dependent aCL were measured by the ELISA method. LA was detected by the dilute aPTT method. ANAs were measured by indirect immunofluorescence on Hep-2 cell slides. We also studied the subsequent pregnancy outcome in 225 patients with a history of two consecutive first-trimester abortions, focusing on ANA. None of the 225 patients had aPL and received any medication or immunotherapy. The prevalence of β2GPI dependent aCL, LA and ANA were 3.3% (10 of 301), 10.0% (30 of 301) and 25.2% (76 of 301), respectively. Four of 301 patients had all antibodies. Regarding ANA in 225 patients with a history of two miscarriages, 39 of the 225 (17.3%) patients had ANAs, as compared with 33 of 740 (4.5%) control women. The prevalence of ANA in patients was significantly higher than that of controls (p < 0.001, Odds Ratio = 4.49). Forty-nine of the 225 (21.8%) recurrent aborters suffered a further abortion, the figures for ANA-negative and ANA-positive patients being 23.1% (43 of 186) and 15.4% (6 of 39) respectively (no significant difference).

β2GPI dependent aCL, LA and ANA define three distinct but partly related populations. ANA is associated in some way with miscarriage, but ANA-positive recurrent aborters with no evidence of aPL do not require medication because the presence of antibodies does not predict subsequent pregnancy loss.p

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ogasawara M., Aoki K., Kajiura S., Yagami Y. Are antinuclear antibodies predictive of recurrent miscarriage? Lancet 1996; 347: 1183–1184.

    Article  PubMed  CAS  Google Scholar 

  2. Aoki K., Dudkiewicz A.B., Matsuura E., Novotny M., Kaberlein G., Gleicher N. Clinical significance ofβ2 glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody detection systems. Am. J. Obstet Gynecol 1995; 172: 926–931.

    Article  PubMed  CAS  Google Scholar 

  3. Ogasawara M., Aoki K., Matsuura E., Sasa H., Yagami Y. Antiβ2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss; Prevalence and clinical association. Lupus 1996; 5: 587–592.

    Article  PubMed  CAS  Google Scholar 

  4. Farquharson R.G., Pearson J.F., John L; Lupus anticoagulant and pregnancy management. Lancet 1984; 28: 228–229.

    Article  Google Scholar 

  5. Xu L., Chang V., Murphy A., Rock J.A., Damewood M., Schlaff W., Zacur H.A. Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. Am. J. Obstet. Gynecol. 1990; 163: 1493–1497.

    PubMed  CAS  Google Scholar 

  6. Maier D.B., Parke A. Subclinical autoimmunity in recurrent aborters. Fertil. Steril. 1989; 51: 280–285.

    PubMed  CAS  Google Scholar 

  7. Laskin C.A., Bombardier C., Hannah M.E., Mandel F.P., Ritchie J.W.K., Farewell V., Farine D., Spitzer K., Fielding L., Soloninka C.A., Yeung M. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N. Engl. J. Med. 1997; 337: 148–153.

    Article  PubMed  CAS  Google Scholar 

  8. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 1994; 179: 457–462.

    Article  PubMed  CAS  Google Scholar 

  9. Ogasawara M., Aoki K., Katano K., Aoyama T., Kajiura S., Suzumori K. Prevalence of autoantibodies in patients with recurrent miscarriages. Am. J. Reprod. Immunol, in press.

    Google Scholar 

  10. Bever E.M., Galli M., Barbui T., Comfurius P., Zwaal RFA. Lupus anticoagulant IgG’s (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 1991; 66: 929–1632.

    Google Scholar 

  11. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulant and other ‘antiphospholipid’ autoantibodies. Blood 1994; 84: 2854–2867.

    PubMed  CAS  Google Scholar 

  12. Sugi T., Mclntyre J.A. Phosphatidylethanolamineinduces specfic conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Thromb. Haemost. 1996; 76: 354–360.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ogasawara, M., Aoki, K., Katano, K., Aoyama, T., Suzumori, K. (1999). Clinical Significance of β2 Glycoprotein I Dependent Anticardiolipin Antibody, Lupus Anticoagulant and Antinuclear Antibodies in Patients with Recurrent Miscarriages. In: Gupta, S.K. (eds) Reproductive Immunology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4197-0_28

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4197-0_28

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5825-4

  • Online ISBN: 978-94-011-4197-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics